# Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations

> **NCT03764722** · PHASE4 · UNKNOWN · sponsor: **Collegium Medicum w Bydgoszczy** · enrollment: 100 (estimated)

## Conditions studied

- Systolic Heart Failure

## Interventions

- **DRUG:** Levosimendan

## Key facts

- **NCT ID:** NCT03764722
- **Lead sponsor:** Collegium Medicum w Bydgoszczy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764722, "Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03764722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*